GR3000418T3 - Preparation of fibrates - Google Patents
Preparation of fibratesInfo
- Publication number
- GR3000418T3 GR3000418T3 GR90400186T GR900400186T GR3000418T3 GR 3000418 T3 GR3000418 T3 GR 3000418T3 GR 90400186 T GR90400186 T GR 90400186T GR 900400186 T GR900400186 T GR 900400186T GR 3000418 T3 GR3000418 T3 GR 3000418T3
- Authority
- GR
- Greece
- Prior art keywords
- fibrates
- preparation
- image
- halogen atom
- chlorobenzamido
- Prior art date
Links
- 229940125753 fibrate Drugs 0.000 title abstract 2
- -1 (4-chlorophenyl)hydroxymethyl Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000000242 4-chlorobenzoyl group Chemical group ClC1=CC=C(C(=O)*)C=C1 0.000 abstract 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C67/00—Preparation of carboxylic acid esters
- C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
- C07C67/31—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of functional groups containing oxygen only in singly bound form
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
- C07C69/708—Ethers
- C07C69/712—Ethers the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Sampling And Sample Adjustment (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Drilling Tools (AREA)
- Polishing Bodies And Polishing Tools (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8606258A FR2598146B1 (fr) | 1986-04-30 | 1986-04-30 | Nouveau procede de preparation de fibrates. |
Publications (1)
Publication Number | Publication Date |
---|---|
GR3000418T3 true GR3000418T3 (en) | 1991-06-28 |
Family
ID=9334781
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GR90400186T GR3000418T3 (en) | 1986-04-30 | 1990-03-30 | Preparation of fibrates |
Country Status (9)
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0725725B2 (ja) * | 1987-07-23 | 1995-03-22 | 保土谷化学工業株式会社 | ベンズアミド誘導体 |
GB2221681A (en) * | 1988-01-22 | 1990-02-14 | Kh Nii Endokrinolog I Khim | Undecylic ether n-chlorophenoxyisobutyric acid and a pharmaceutical preparation for treating hyperlipemia based on it |
US5008439A (en) * | 1988-03-21 | 1991-04-16 | Hoechst Celanese Corporation | Synthesis of 2-(4-hydroxyphenoxy) alkanoic acid esters |
IL102707A (en) * | 1992-08-02 | 1996-11-14 | Cherkez Stephen | Processes for the preparation of tyramine derivatives |
EP0625504B1 (de) | 1993-05-12 | 1997-08-27 | HEUMANN PHARMA GmbH | Stabile und kristalline Form von Bezafibrat |
US5412112A (en) * | 1994-06-14 | 1995-05-02 | Industrial Technology Research Institute | Derivatives and preparation of 2,2-dimethyl-5-substituted phenoxy-pentanoic acids |
US6838091B2 (en) | 1998-12-18 | 2005-01-04 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
US6814977B1 (en) | 1998-12-18 | 2004-11-09 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
US7014864B1 (en) | 1998-12-18 | 2006-03-21 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
US6180138B1 (en) | 1999-01-29 | 2001-01-30 | Abbott Laboratories | Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption |
US6368622B2 (en) | 1999-01-29 | 2002-04-09 | Abbott Laboratories | Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption |
US6383517B1 (en) | 1999-01-29 | 2002-05-07 | Abbott Laboratories | Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption |
US6719999B2 (en) | 1999-03-31 | 2004-04-13 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
US6372251B2 (en) | 1999-06-11 | 2002-04-16 | Abbott Laboratories | Formulations comprising lipid-regulating agents |
US6982251B2 (en) * | 2000-12-20 | 2006-01-03 | Schering Corporation | Substituted 2-azetidinones useful as hypocholesterolemic agents |
BR0206644A (pt) * | 2001-01-26 | 2004-02-25 | Schering Corp | Combinações de inibidor(es) de absorção de esteróis com agente(s) cardiovascular(es) para o tratamento de condições vasculares |
MXPA03006727A (es) * | 2001-01-26 | 2003-10-24 | Schering Corp | Combinaciones de acido nicotinico y derivados del mismo con inhibidor(es) de la absorcion de los esteroles, y tratamiento para indicaciones vasculares. |
US20060287254A1 (en) * | 2001-01-26 | 2006-12-21 | Schering Corporation | Use of substituted azetidinone compounds for the treatment of sitosterolemia |
US7071181B2 (en) * | 2001-01-26 | 2006-07-04 | Schering Corporation | Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors |
CA2434504A1 (en) * | 2001-01-26 | 2002-08-01 | Teddy Kosoglou | Combinations of sterol absorption inhibitor(s) with blood modifiers for treating vascular conditions |
ES2290562T3 (es) * | 2001-01-26 | 2008-02-16 | Schering Corporation | Combinaciones del activador del receptor activado por el proliferador de los peroxisomas (ppar) fenofibrato con el inhibidor de la absorcion de esteroles ezetimiba para indicaciones vasculares. |
ES2287250T3 (es) * | 2001-01-26 | 2007-12-16 | Schering Corporation | Combinaciones de secuestrante(s) de acidos biliares e inhibidor(es) de la absorcion de esteroles y tratamientos para indicaciones vasculares. |
KR20070120617A (ko) * | 2001-01-26 | 2007-12-24 | 쉐링 코포레이션 | 치환된 아제티딘온 화합물을 포함하는 약제학적 조성물 |
ITMI20010203A1 (it) * | 2001-02-02 | 2002-08-02 | Solchem Italiana Spa | Processo per la preparazione di fibrati |
ITMI20010936A1 (it) * | 2001-05-08 | 2002-11-08 | Laboratorio Chimico Int Spa | Processo per la produzione di acidi 2-4-(2,2-dialociclopropil)fenossi|-alcanoici e loro esteri |
WO2002096415A2 (en) * | 2001-05-25 | 2002-12-05 | Schering Corporation | Use of azetidinone substituted derivatives in the treatment of alzheimer's disease |
US7053080B2 (en) * | 2001-09-21 | 2006-05-30 | Schering Corporation | Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors |
ES2272776T3 (es) * | 2001-09-21 | 2007-05-01 | Schering Corporation | Tratamiento de xantomas con derivados de azetidinona como inhibidores de la absorcion de esterol. |
US20030119808A1 (en) * | 2001-09-21 | 2003-06-26 | Schering Corporation | Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects |
US7056906B2 (en) * | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
BR0212907A (pt) * | 2001-09-21 | 2004-10-13 | Schering Corp | Métodos para tratamento ou prevenção de inflamação vascular usando inibidor(es) da absorção de esteróis |
WO2004043456A1 (en) * | 2002-11-06 | 2004-05-27 | Schering Corporation | Cholesterol absorption inhibitors for the treatment of demyelination |
US7208486B2 (en) * | 2003-03-07 | 2007-04-24 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
DE602004016123D1 (de) * | 2003-03-07 | 2008-10-09 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
US7192944B2 (en) | 2003-03-07 | 2007-03-20 | Schering Corp. | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
US7459442B2 (en) * | 2003-03-07 | 2008-12-02 | Schering Corporation | Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
CA2544309A1 (en) * | 2003-11-05 | 2005-05-26 | Schering Corporation | Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions |
US8062664B2 (en) * | 2003-11-12 | 2011-11-22 | Abbott Laboratories | Process for preparing formulations of lipid-regulating drugs |
FR2892721B1 (fr) * | 2005-10-28 | 2009-07-24 | Synkem Sa | Nouveau procede de preparation de sels d'acides et d'ammonium quaternaires |
EP1837327A1 (en) * | 2006-03-23 | 2007-09-26 | SOLMAG S.p.A. | Method for preparing pure fenofibrate |
KR20100062976A (ko) * | 2007-07-05 | 2010-06-10 | 피노르가 에스.에이. | 페노피브레이트의 제조방법 |
CN103373921B (zh) | 2012-04-26 | 2016-08-10 | 浙江海正药业股份有限公司 | 4-((取代苯基)二氟甲基)苯氧基羧酸衍生物及其制备方法和医药用途 |
US11427528B2 (en) | 2016-07-29 | 2022-08-30 | Hangzhou Solipharma Co., Ltd. | Fenofibrate crystalline form and manufacturing method thereof |
CN107698422A (zh) * | 2017-08-21 | 2018-02-16 | 赵剑锋 | 一种2‑[4‑(4‑ 氯苯甲酰) 苯氧基]‑2‑ 甲基丙酸的合成工艺 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2060573A1 (de) * | 1969-12-18 | 1971-06-24 | Ciba Geigy Ag | Neue Carbonsaeuren und Verfahren zu ihrer Herstellung |
US3795691A (en) * | 1971-06-23 | 1974-03-05 | American Home Prod | Cholesterol-lowering agents |
US3759950A (en) * | 1971-09-20 | 1973-09-18 | American Home Prod | 2-phenoxyalkanoic acid esters |
CH626318A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1977-03-08 | 1981-11-13 | Ciba Geigy Ag | |
IT1141655B (it) * | 1980-02-12 | 1986-10-08 | Schiapparelli Spa | Nuovi derivati dell'acido propanoico ad attivita' ipolipidemica e ipocolesterolemica |
DE3150233A1 (de) * | 1981-12-18 | 1983-06-30 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von 2-(hydroxiphenoxi)-carbonsaeureestern |
US4661505A (en) * | 1982-11-03 | 1987-04-28 | Eli Lilly And Company | Leukotriene antagonists |
IL71668A (en) * | 1983-05-13 | 1988-07-31 | Dow Chemical Co | Method of preparing esters of aryloxyphenoxy propanoic acid |
-
1986
- 1986-04-30 FR FR8606258A patent/FR2598146B1/fr not_active Expired
-
1987
- 1987-04-27 AT AT87400967T patent/ATE49195T1/de not_active IP Right Cessation
- 1987-04-27 ES ES87400967T patent/ES2005059B3/es not_active Expired - Lifetime
- 1987-04-27 EP EP87400967A patent/EP0245156B1/fr not_active Expired - Lifetime
- 1987-04-27 DE DE8787400967T patent/DE3761307D1/de not_active Expired - Lifetime
- 1987-04-27 US US07/043,184 patent/US4739101A/en not_active Expired - Lifetime
- 1987-04-27 CA CA000535685A patent/CA1282424C/en not_active Expired - Lifetime
- 1987-04-28 JP JP62106179A patent/JPS62263146A/ja active Granted
-
1990
- 1990-03-30 GR GR90400186T patent/GR3000418T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US4739101A (en) | 1988-04-19 |
ES2005059B3 (es) | 1990-03-16 |
EP0245156B1 (fr) | 1990-01-03 |
FR2598146B1 (fr) | 1989-01-20 |
ATE49195T1 (de) | 1990-01-15 |
DE3761307D1 (de) | 1990-02-08 |
ES2005059A4 (es) | 1989-03-01 |
EP0245156A1 (fr) | 1987-11-11 |
CA1282424C (en) | 1991-04-02 |
JPH0529343B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-04-30 |
FR2598146A1 (fr) | 1987-11-06 |
JPS62263146A (ja) | 1987-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3000418T3 (en) | Preparation of fibrates | |
WO1988000042A1 (en) | New 5-alkoxy-2,4-diamino-alkyl benzols, and hair tinting means using them | |
AU575306B2 (en) | Proline derivatives | |
ES548357A0 (es) | Procedimiento para preparar derivados de n-(adamantil-1)-pirrolidon-5-carboxamida-2. | |
AU4611589A (en) | Enzyme-inhibiting amino acid derivatives, a process for the preparation thereof, agents containing these, and the use thereof. | |
ES545009A0 (es) | Procedimiento de preparacion de nuevas fenil-naftiridinas. | |
AU568064B2 (en) | 4-acylamino-1-aza-adamantanes | |
ES2066756T3 (es) | Nuevos derivados de tironina. | |
ATE101391T1 (de) | Verfahren zur herstellung von in stellung 3 durch eine halogenierte gesaettigte kette substituierten cyclopropancarbonsaeurederivaten. | |
ES2006700B3 (es) | Nuevos derivados de tironina. | |
DE68910931D1 (de) | Verfahren zur Herstellung von Propionsäurederivaten. | |
AU2172688A (en) | Preparation of dien-1-ols, 9-hydroxydodec-10-enyl 1-tert-butyl ether and use thereof as an intermediate for synthesizing, 8,10-dodecadienol | |
BR9106128A (pt) | Sulfetos de n-acil-aminoalquil-2-hidroxietila e um processo para sua preparacao | |
ES2043631T3 (es) | Procedimiento de preparacion de hidroxialquilxantinas. | |
ES2070121T3 (es) | Procedimiento para la preparacion de 4-alcoxialquil-beta-carbolinas. | |
DE3660546D1 (en) | Phosphoroimidates | |
AT383811B (de) | Verfahren zur herstellung von monoalkalisalzen von 7-amino-3-cephem-4-carbonsaeurederivaten | |
ES536140A0 (es) | Procedimiento para la preparacion de quinolinonas-4 | |
ES2013316A6 (es) | Un proceso para preparar un derivado de guanidinotiazol | |
DK74594A (da) | Fremgangsmåde til fremstilling af paroxetin eller et farmaceutisk acceptabelt salt deraf |